Results 1 to 10 of about 409,767 (250)

Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review

open access: yesFrontiers in Immunology, 2021
BackgroundThe combination of immune checkpoint inhibitors (ICIs) and thoracic radiotherapy (TRT) has shown significant clinical activity in patients with non-small cell lung cancer (NSCLC).
Butuo Li   +8 more
doaj   +1 more source

Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study

open access: yesFrontiers in Pharmacology, 2023
Background: The musculoskeletal toxicity of immune checkpoint inhibitors (ICIs) is receiving increasing attention with clinical experience. Nevertheless, the absence of a systematic investigation into the musculoskeletal toxicity profile of ICIs ...
Hao Liu   +8 more
doaj   +1 more source

Ethnobotany and Phytopharmacology of Avena sativa: A Qualitative Review

open access: yesSciences of Phytochemistry, 2023
Among all cereals, oat is considered to be one of the goods consumed in functional grain, nutraceutical, and pharmaceutical components. The review article aims to explore plant profile, phytochemical constituents present in different parts, and potential
Shuby Kumari   +6 more
doaj   +1 more source

Review of Functional Aspects of Nanocellulose-Based Pickering Emulsifier for Non-Toxic Application and Its Colloid Stabilization Mechanism

open access: yesMolecules, 2022
In the past few years, the research on particle-stabilized emulsion (Pickering emulsion) has mainly focused on the usage of inorganic particles with well-defined shapes, narrow size distributions, and chemical tunability of the surfaces such as silica ...
Shao Hui Teo   +4 more
doaj   +1 more source

Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review

open access: yesFrontiers in Immunology, 2022
BackgroundTherapies based on the combination of immune checkpoint inhibitors (ICIs) and thoracic radiotherapy (TRT) are transforming the treatment landscape of esophageal cancer.
Tongzhen Xu   +3 more
doaj   +1 more source

Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients

open access: yesMedicines, 2018
Background: Despite improvement of tumor response rates, targeted therapy may induce toxicities in cancer patients. Recent studies indicate amelioration of adverse events (AEs) by add-on mistletoe (Viscum album L., VA) in standard oncological treatment ...
Anja Thronicke   +4 more
doaj   +1 more source

Pesticide Toxicity Profile: Bipyridylium Herbicides

open access: yesEDIS, 2005
This document provides a general overview of human toxicity, provides a listing of laboratory animal and wildlife toxicities and a cross reference of chemical, common and trade names of the bipyridylium herbicides registered for use in Florida.
Frederick M. Fishel
doaj   +5 more sources

Pesticide Toxicity Profile: Miscellaneous Rodenticides

open access: yesEDIS, 2005
This document provides a general overview of human toxicity, provides a listing of laboratory animal and wildlife toxicities and a cross reference of chemical, common and trade names of miscellaneous rodenticides registered for use in Florida.
Frederick M. Fishel
doaj   +5 more sources

Pesticide Toxicity Profile: Carbamate Pesticides

open access: yesEDIS, 2005
This document provides a general overview of human toxicity, provides a listing of laboratory animal and wildlife toxicities and a cross-reference of chemical, common and trade names of many carbamate pesticides registered for use in Florida.
Frederick M. Fishel
doaj   +5 more sources

1,4-Dioxane: A Narrative Review of Its Pharmacological and Toxicological Attributes [PDF]

open access: yesالمجلة العراقية للصيدلة
Background: 1,4-dioxane (DX) was first discovered in 1863 and has been made accessible for commercial purposes around the 1930s as a solvent for cellulose and in the production of plastics.
Marwa Mohammed Alshaher   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy